Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England

Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin–Producing Enteroaggregative Escherichia coli O104:H4

(2012) Martin Nitschke et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli

(2012) C. Jenkins et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Azithromycin and decolonization after HUS

(2012) Michael E. Seifert et al.   Nature Reviews Nephrology

Investigation of an Escherichia coli O145 outbreak in a child day-care centre - extensive sampling and characterization of eae- and stx 1-positive E. coli yields epidemiological and socioeconomic insight

(2011) Erik Wahl et al.   BMC INFECTIOUS DISEASES

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice

(2011) Clarence C Tam et al.   GUT

Escherichia coli O157

(2010) Hugh Pennington   LANCET

Primary and secondary cases in Escherichia coliO157 outbreaks: a statistical analysis

(2009) Kate G Snedeker et al.   BMC INFECTIOUS DISEASES

Hemolytic Uremic Syndrome and Death in Persons withEscherichia coliO157:H7 Infection, Foodborne Diseases Active Surveillance Network Sites, 2000–2006

(2009) L. Hannah Gould et al.   CLINICAL INFECTIOUS DISEASES